Fidelity European Trust plc: 13.6% NAV and 17.5% share price returns over 12 months

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for the period ended May 2023.

Portfolio Manager Commentary
Continental European equities retreated in May, amid weakening economic data from China and concerns that US policymakers may not reach an agreement to extend the Federal debt limit. Markets welcomed the “debt ceiling deal” at month end, but sought safety in risk-off sectors following downbeat economic readings from China. European markets were also hurt as Germany, the region’s largest economy, edged into recessionary territory in the first quarter of the year. The European Central Bank delivered the expected rate hike of 0.25% in May, following a modest cooldown in core inflation in March and the continued rapid tightening in lending.

In May, the Trust recorded negative returns but outperformed the index. The outperformance was driven by favourable positioning in technology, and strong stock picking in financials and health care. At a stock level, Dutch chipmaker ASML rose, as semiconductor businesses gained after US chipmaker giant NVIDIA reported upbeat quarterly results and forecasts, anticipating a surge in demand for artificial intelligence chips. Private equity company 3i Group reported annual revenue growth of 30% for FY22. The strategy employs an active, bottom-up stock picking approach, which focuses on finding attractively valued companies that can deliver sustainable dividend growth over time.

On a rolling 12-month basis, the Trust recorded NAV and share price returns of 13.6% and 17.5% respectively, compared to 8.5% for the index.

Fidelity European Trust PLC (LON:FEV) is a European investment trust. It  aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

16.7% YTD return hails Fidelity European Trust’s strong credentials

Despite market headwinds, the Trust demonstrated resilience with standout contributions from Legrand and EQT and positive sector positioning. Over the past 12 months, NAV rose 2.3% and share price 5.5%, reflecting our focus on cash‑generative, dividend‑growing companies.

Fidelity European Trust May Factsheet – European equities moved higher

European equities rose in May amid volatility linked to US trade uncertainty. Fidelity European Trust underperformed the index, mainly due to weak positions in consumer sectors.

Search

Search